Grand Teton Research Group | Idaho Falls, ID
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Note: Participants with a history of active TB with documentation of treatment by the Centers for Disease Control (CDC) and/or World Health Organization (WHO) criteria prior to the originator study are not excluded from the study.
Primary purpose
Allocation
Interventional model
Masking
778 participants in 2 patient groups
Loading...
Central trial contact
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal